RVMDW (STOCKS)
Revolution Medicines, Inc. Warrant
—
Change: —
Prev close: —
Company Information
- Exchange
- XNAS
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 809
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $15.13M |
| Operating Expenses | $1.39B |
| Research and Development | $1.13B |
| Other Operating Expenses | $261.28M |
| Operating Income/Loss | -$1.39B |
| Income/Loss From Continuing Operations After Tax | -$1.37B |
| Income/Loss From Continuing Operations Before Tax | -$1.37B |
| Net Income/Loss | -$1.37B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.37B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.37B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.10 |
| Diluted Earnings Per Share | -$7.10 |
| Basic Average Shares | 577,384,491 |
| Diluted Average Shares | 577,384,491 |
| Assets | $2.25B |
| Current Assets | $1.97B |
| Noncurrent Assets | $285.82M |
| Fixed Assets | $31.48M |
| Intangible Assets | $55.80M |
| Other Non-current Assets | $198.55M |
| Liabilities | $753.82M |
| Current Liabilities | $289.60M |
| Accounts Payable | $80.54M |
| Other Current Liabilities | $209.06M |
| Noncurrent Liabilities | $464.22M |
| Equity | $1.50B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.50B |
| Liabilities And Equity | $2.25B |
| Net Cash Flow From Operating Activities | -$1.06B |
| Net Cash Flow From Operating Activities, Continuing | -$1.06B |
| Net Cash Flow From Investing Activities | $306.62M |
| Net Cash Flow From Investing Activities, Continuing | $306.62M |
| Net Cash Flow From Financing Activities | $859.39M |
| Net Cash Flow From Financing Activities, Continuing | $859.39M |
| Net Cash Flow | $108.55M |
| Net Cash Flow, Continuing | $108.55M |
| Comprehensive Income/Loss | -$1.37B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$1.37B |
| Other Comprehensive Income/Loss | -$307.12M |